Jagsonpal Pharmaceuticals Ltd.

•
₹ 236.541.52%

2026-08-21

jagsonpal.comBSE: 507789NSE: JAGSNPHARM
Market Cap₹ 1,516 Cr.
Current Price₹ 233
High / Low₹ 264 / 155
Stock P/E0.0
Book Value₹ 38
Price to Book6.58
Dividend Yield1.74 %
ROCE33.1 %
ROE28.5 %
Face Value₹ 2

Add ratio to table

ABOUT

KEY POINTS

Revenue Breakup Mar 2020 • Pharmaceutical: 100.0%

PROS

  • Company has delivered good profit growth of 47.7% CAGR over last 5 years
  • Company is almost debt free
  • Company has a healthy return on capital (ROCE) of 25.0%
  • Company has a good return on equity (ROE) track record: 3 Years ROE 20.5%
  • Operating margins have improved to 18.1% from 11.7%
  • Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.31x)

CONS

  • Recent results are weak - TTM profit is down 24.4% versus prior year
  • Recurring exceptional / one-off items are inflating headline profit
  • Stock is trading at 6.6x its book value

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

EDIT COLUMNS
HealthcareHealthcarePharmaceuticals & Drugs
Part ofNIFTY 50NIFTY 500NIFTY LARGEMIDCAP 250NIFTY 100NIFTY 200
S.No.NameCMP Rs.P/EMar Cap Rs.Cr.Div Yld %NP Qtr Rs.Cr.Qtr Profit Var %Sales Qtr Rs.Cr.Qtr Sales Var %ROCE %OPM %
1.SUNPHARMA1898.0037.65455393.780.842901.2326.5315299.8810.9819.1128.81
2.DIVISLAB8525.0077.37226311.960.35902.0065.503080.0027.8021.5140.75
3.TORNTPHARM5013.0087.43190678.410.76566.003.284921.0057.3219.2733.81
4.CIPLA1416.0033.94114392.010.92785.55-39.187119.284.1316.0016.73
5.ZYDUSLIFE1105.0024.42110224.170.09990.20-34.908017.0023.9721.3924.54
6.LUPIN2220.0018.36101506.150.811416.9816.018276.8934.2828.8629.59
7.MANKIND2391.0048.3498747.340.04574.0929.124030.5912.8913.2426.30
8.DRREDDY1171.0030.3397740.540.68435.60-69.108099.80-5.2113.7510.63
9.LAURUSLABS1807.0089.3097634.420.11362.07123.942026.3129.1018.2031.50
10.AUROPHARMA1615.1525.0392932.160.251032.0325.229150.3517.4412.7620.54
11.BIOCON414.30136.3267518.230.12136.8053.364336.0010.893.2619.54
12.JAGSNPHARM229.900.001515.721.7413.1922.1282.238.7633.1420.97
Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2023
60
52
Operating Profit
—
OPM %
—
Other Income
2
Interest
0
Depreciation
0
10
Tax %
25.87%
Net Profit
7
3
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Sep 2023
58
49
Operating Profit
—
OPM %
—
Other Income
2
Interest
0
Depreciation
0
10
Tax %
25.00%
Net Profit
7
3
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Dec 2023
47
44
Operating Profit
—
OPM %
—
Other Income
3
Interest
0
Depreciation
0
5
Tax %
25.00%
Net Profit
4
1
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Mar 2024
43
41
Operating Profit
—
OPM %
—
Other Income
2
Interest
0
Depreciation
0
5
Tax %
21.81%
Net Profit
4
1
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Jun 2024
61
51
Operating Profit
—
OPM %
—
Other Income
1
Interest
0
Depreciation
1
7
Tax %
25.04%
Net Profit
5
1
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Sep 2024
75
58
Operating Profit
—
OPM %
—
Other Income
2
Interest
0
Depreciation
2
15
Tax %
25.44%
Net Profit
11
2
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Dec 2024
74
58
Operating Profit
—
OPM %
—
Other Income
2
Interest
0
Depreciation
2
39
Tax %
17.27%
Net Profit
32
5
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Mar 2025
59
50
Operating Profit
—
OPM %
—
Other Income
3
Interest
0
Depreciation
2
9
Tax %
24.45%
Net Profit
7
1
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Jun 2025
76
61
Operating Profit
—
OPM %
—
Other Income
3
Interest
0
Depreciation
2
14
Tax %
25.23%
Net Profit
11
2
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Sep 2025
74
58
Operating Profit
—
OPM %
—
Other Income
3
Interest
0
Depreciation
2
17
Tax %
25.22%
Net Profit
13
2
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Dec 2025
73
57
Operating Profit
—
OPM %
—
Other Income
3
Interest
0
Depreciation
2
15
Tax %
24.59%
Net Profit
11
2
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Mar 2026
64
53
Operating Profit
—
OPM %
—
Other Income
3
Interest
0
Depreciation
2
12
Tax %
25.43%
Net Profit
9
1
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Jun 2026
82
67
Operating Profit
—
OPM %
—
Other Income
3
Interest
0
Depreciation
2
18
Tax %
25.40%
Net Profit
13
0
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
13
Reserves
0
Promoter Pledge %
0.00%

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016
143
132
Operating Profit
12
OPM %
9
Other Income
1
Interest
5
Depreciation
3
4
Tax %
20
Net Profit
3
EPS
0
Dividend Payout %
8
Minority Interest
0
Share of Associates
0
Adjusted EPS
0
Minority Interest
0
Share of Associates
0
Adjusted EPS
0
Mar 2017
144
138
Operating Profit
6
OPM %
4
Other Income
0
Interest
3
Depreciation
2
14
Tax %
18
Net Profit
12
EPS
5
Dividend Payout %
2
Minority Interest
0
Share of Associates
0
Adjusted EPS
2
Minority Interest
0
Share of Associates
0
Adjusted EPS
2
Mar 2018
127
138
Operating Profit
-11
OPM %
-8
Other Income
0
Interest
1
Depreciation
0
-12
Tax %
1
Net Profit
-12
EPS
-4
Dividend Payout %
-2
Minority Interest
0
Share of Associates
0
Adjusted EPS
-2
Minority Interest
0
Share of Associates
0
Adjusted EPS
-2
Mar 2019
167
157
Operating Profit
11
OPM %
6
Other Income
1
Interest
1
Depreciation
1
9
Tax %
20
Net Profit
7
EPS
3
Dividend Payout %
9
Minority Interest
0
Share of Associates
0
Adjusted EPS
1
Minority Interest
0
Share of Associates
0
Adjusted EPS
1
Mar 2020
159
150
Operating Profit
11
OPM %
7
Other Income
3
Interest
1
Depreciation
1
9
Tax %
16
Net Profit
8
EPS
3
Dividend Payout %
17
Minority Interest
0
Share of Associates
0
Adjusted EPS
1
Minority Interest
0
Share of Associates
0
Adjusted EPS
1
Mar 2021
188
169
Operating Profit
23
OPM %
12
Other Income
4
Interest
1
Depreciation
1
22
Tax %
22
Net Profit
17
EPS
7
Dividend Payout %
15
Minority Interest
0
Share of Associates
0
Adjusted EPS
3
Minority Interest
0
Share of Associates
0
Adjusted EPS
3
Mar 2022
218
193
Operating Profit
28
OPM %
13
Other Income
3
Interest
0
Depreciation
2
27
Tax %
29
Net Profit
19
EPS
7
Dividend Payout %
56
Minority Interest
0
Share of Associates
0
Adjusted EPS
3
Minority Interest
0
Share of Associates
0
Adjusted EPS
3
Mar 2023
237
203
Operating Profit
40
OPM %
17
Other Income
6
Interest
0
Depreciation
1
35
Tax %
23
Net Profit
27
EPS
10
Dividend Payout %
49
Minority Interest
0
Share of Associates
0
Adjusted EPS
4
Minority Interest
0
Share of Associates
0
Adjusted EPS
4
Mar 2024
209
186
Operating Profit
32
OPM %
15
Other Income
9
Interest
1
Depreciation
2
30
Tax %
25
Net Profit
22
EPS
8
Dividend Payout %
59
Minority Interest
0
Share of Associates
0
Adjusted EPS
3
Minority Interest
0
Share of Associates
0
Adjusted EPS
3
Mar 2025
269
218
Operating Profit
59
OPM %
22
Other Income
8
Interest
1
Depreciation
8
70
Tax %
21
Net Profit
55
EPS
8
Dividend Payout %
30
Minority Interest
0
Share of Associates
0
Adjusted EPS
8
Minority Interest
0
Share of Associates
0
Adjusted EPS
8
TTM
294
235
Operating Profit
—
OPM %
—
Other Income
12
Interest
1
Depreciation
9
61
Tax %
25
Net Profit
45
EPS
—
Dividend Payout %
—
Minority Interest
0
Share of Associates
0
Adjusted EPS
—
Minority Interest
0
Share of Associates
0
Adjusted EPS
—

COMPOUNDED SALES GROWTH

10 Years:
7%
5 Years:
11%
3 Years:
7%

COMPOUNDED PROFIT GROWTH

10 Years:
47%
5 Years:
48%
3 Years:
43%

STOCK PRICE CAGR

10 Years:
32%
5 Years:
31%
3 Years:
9%
1 Year:
-5%

RETURN ON EQUITY

10 Years:
11%
5 Years:
18%
3 Years:
20%
Last Year:
29%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Corporate actions

2026

May 4

₹ 250.00

Buy Back of Shares Inter alia considered and approved the proposal for buyback of equity shares of the Company in compliance with Securities and Exchange Board of India (Buy-Back of Securities) Regulations, 2018 (SEBI Buyback Regulations), subject to approval of the shareholders and other applicable statutory approvals, as may be required. The details pertaining to proposed Buyback is as under 1. Upto 16,00,000 (16 lakhs) equity shares (representing 2.39% of the paid-up equity capital of the Company 2. Buy back Price : Rs. 250.00 per equity shares (Rupees Two Hundred and Fifty Only) 3. Maximum Buyback Offer size : Rs. 40,00,00,000 (Rupees Forty Crores only), representing 18.35% of the paid-up equity share capital and free reserves as per audited financial statements as at March 31, 2025 The Maximum Buyback Offer Size does not include expenses such as brokerage costs, fees, turnover charges, securities transaction tax, goods and services tax (if any), stamp duty, filing fees payable to SEBI, stock exchange charges, advisors? and legal fees, printing and dispatch expenses, public announcement publication expenses and other incidental and related expenses. Method of Buyback The Buyback will be undertaken through the ?tender offer? route on a proportionate basis in accordance with the provisions of the SEBI Buyback Regulations Other details: ? Centrum Capital Limited, a SEBI registered Merchant Banker, has been appointed as the Manager to the Buyback. ? The Board has constituted a ?Buyback Committee? and delegated necessary powers to it, including fixing the record date and undertaking actions in relation to the proposed Buyback. ? Mr. Pratham Rawal, Company Secretary & Compliance Officer, has been designated as the Compliance Officer for the Buyback. ? The Promoters/Promoter Group will not be participating in the proposed Buyback. ? Details of Postal ballot for seeking shareholder approval for the proposed Buyback will be intimated separately

Mar 2016
Equity Capital
13
85
38
Trade Payables
10
13
Total Liabilities
159
52
Capital Work in Progress
0
0
40
0
Cash & Bank
16
52
Total Assets
159
Total Debt
38
Net Working Capital
44
Contingent Liabilities
3
Book Value per Share
34.55
Face Value
5.00
Total Debt
38
Net Working Capital
44
Contingent Liabilities
3
Book Value per Share
34.55
Face Value
5.00
Mar 2017
Equity Capital
13
97
8
Trade Payables
9
16
Total Liabilities
143
22
Capital Work in Progress
0
0
48
0
Cash & Bank
20
53
Total Assets
143
Total Debt
8
Net Working Capital
81
Contingent Liabilities
2
Book Value per Share
38.96
Face Value
5.00
Total Debt
8
Net Working Capital
81
Contingent Liabilities
2
Book Value per Share
38.96
Face Value
5.00
Mar 2018
Equity Capital
13
85
8
Trade Payables
9
14
Total Liabilities
130
21
Capital Work in Progress
1
0
51
0
Cash & Bank
15
42
Total Assets
130
Total Debt
8
Net Working Capital
66
Contingent Liabilities
2
Book Value per Share
34.43
Face Value
5.00
Total Debt
8
Net Working Capital
66
Contingent Liabilities
2
Book Value per Share
34.43
Face Value
5.00
Mar 2019
Equity Capital
13
91
4
Trade Payables
12
16
Total Liabilities
136
22
Capital Work in Progress
2
0
33
0
Cash & Bank
39
41
Total Assets
136
Total Debt
4
Net Working Capital
69
Contingent Liabilities
1
Book Value per Share
36.89
Face Value
5.00
Total Debt
4
Net Working Capital
69
Contingent Liabilities
1
Book Value per Share
36.89
Face Value
5.00
Mar 2020
Equity Capital
13
98
6
Trade Payables
12
20
Total Liabilities
149
24
Capital Work in Progress
2
11
29
0
Cash & Bank
40
41
Total Assets
149
Total Debt
6
Net Working Capital
62
Contingent Liabilities
6
Book Value per Share
39.39
Face Value
5.00
Total Debt
6
Net Working Capital
62
Contingent Liabilities
6
Book Value per Share
39.39
Face Value
5.00
Mar 2021
Equity Capital
13
109
7
Trade Payables
18
17
Total Liabilities
164
26
Capital Work in Progress
0
15
30
0
Cash & Bank
60
33
Total Assets
164
Total Debt
7
Net Working Capital
80
Contingent Liabilities
8
Book Value per Share
43.55
Face Value
5.00
Total Debt
7
Net Working Capital
80
Contingent Liabilities
8
Book Value per Share
43.55
Face Value
5.00
Mar 2022
Equity Capital
13
120
0
Trade Payables
19
20
Total Liabilities
171
23
Capital Work in Progress
0
51
30
0
Cash & Bank
25
43
Total Assets
171
Total Debt
0
Net Working Capital
82
Contingent Liabilities
8
Book Value per Share
50.68
Face Value
5.00
Total Debt
0
Net Working Capital
82
Contingent Liabilities
8
Book Value per Share
50.68
Face Value
5.00
Mar 2023
Equity Capital
13
137
0
Trade Payables
17
36
Total Liabilities
203
24
Capital Work in Progress
0
1
21
0
Cash & Bank
115
42
Total Assets
203
Total Debt
0
Net Working Capital
137
Contingent Liabilities
6
Book Value per Share
57.30
Face Value
5.00
Total Debt
0
Net Working Capital
137
Contingent Liabilities
6
Book Value per Share
57.30
Face Value
5.00
Mar 2024
Equity Capital
13
157
0
Trade Payables
8
47
Total Liabilities
225
9
Capital Work in Progress
0
0
15
11
Cash & Bank
148
41
Total Assets
225
Total Debt
0
Net Working Capital
160
Contingent Liabilities
11
Book Value per Share
64.43
Face Value
5.00
Total Debt
0
Net Working Capital
160
Contingent Liabilities
11
Book Value per Share
64.43
Face Value
5.00
Mar 2025
Equity Capital
13
205
0
Trade Payables
10
64
Total Liabilities
292
94
Capital Work in Progress
0
0
15
13
Cash & Bank
129
40
Total Assets
292
Total Debt
0
Net Working Capital
135
Contingent Liabilities
16
Book Value per Share
32.83
Face Value
2.00
Total Debt
0
Net Working Capital
135
Contingent Liabilities
16
Book Value per Share
32.83
Face Value
2.00

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016
9
Cash from Investing
-2
Cash from Financing
-6
1
Free Cash Flow
6
OCF / Net Profit
2.78
Cumulative 5-Year FCF
0
OCF / Net Profit
2.78
Cumulative 5-Year FCF
0
Mar 2017
-3
Cash from Investing
41
Cash from Financing
-34
5
Free Cash Flow
-3
OCF / Net Profit
-0.27
Cumulative 5-Year FCF
0
OCF / Net Profit
-0.27
Cumulative 5-Year FCF
0
Mar 2018
-2
Cash from Investing
-3
Cash from Financing
-1
-6
Free Cash Flow
-3
OCF / Net Profit
0.14
Cumulative 5-Year FCF
0
OCF / Net Profit
0.14
Cumulative 5-Year FCF
0
Mar 2019
31
Cash from Investing
-1
Cash from Financing
-6
24
Free Cash Flow
29
OCF / Net Profit
4.28
Cumulative 5-Year FCF
0
OCF / Net Profit
4.28
Cumulative 5-Year FCF
0
Mar 2020
12
Cash from Investing
-11
Cash from Financing
-2
-1
Free Cash Flow
9
OCF / Net Profit
1.51
Cumulative 5-Year FCF
37
OCF / Net Profit
1.51
Cumulative 5-Year FCF
37
Mar 2021
28
Cash from Investing
-2
Cash from Financing
-7
19
Free Cash Flow
28
OCF / Net Profit
1.65
Cumulative 5-Year FCF
59
OCF / Net Profit
1.65
Cumulative 5-Year FCF
59
Mar 2022
7
Cash from Investing
-26
Cash from Financing
-18
-36
Free Cash Flow
7
OCF / Net Profit
0.37
Cumulative 5-Year FCF
69
OCF / Net Profit
0.37
Cumulative 5-Year FCF
69
Mar 2023
47
Cash from Investing
-58
Cash from Financing
-0
-11
Free Cash Flow
47
OCF / Net Profit
1.75
Cumulative 5-Year FCF
119
OCF / Net Profit
1.75
Cumulative 5-Year FCF
119
Mar 2024
35
Cash from Investing
-25
Cash from Financing
-9
2
Free Cash Flow
35
OCF / Net Profit
1.57
Cumulative 5-Year FCF
126
OCF / Net Profit
1.57
Cumulative 5-Year FCF
126
Mar 2025
55
Cash from Investing
-45
Cash from Financing
-12
-2
Free Cash Flow
-36
OCF / Net Profit
1.00
Cumulative 5-Year FCF
81
OCF / Net Profit
1.00
Cumulative 5-Year FCF
81

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016
EPS (₹)
1.24
Book Value (₹)
34.55
Dividend per Share (₹)
0.10
Cash EPS (₹)
0.97
Operating Margin %
8.65%
Net Margin %
2.26%
ROE %
3.65%
ROCE %
7.32%
2.08%
Debtor Days
110
Inventory Days
92
Payable Days
43
159
Debt to Equity (x)
0.43x
Interest Coverage (x)
1.77x
1.76x
Revenue Growth %
3.86%
Operating Profit Growth %
41.06%
Net Profit Growth %
177.88%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2017
EPS (₹)
4.53
Book Value (₹)
38.96
Dividend per Share (₹)
0.10
Cash EPS (₹)
2.12
Operating Margin %
4.30%
Net Margin %
8.18%
ROE %
12.32%
ROCE %
14.26%
7.86%
Debtor Days
102
Inventory Days
110
Payable Days
49
163
Debt to Equity (x)
0.08x
Interest Coverage (x)
6.44x
3.74x
Revenue Growth %
0.27%
Operating Profit Growth %
-49.96%
Net Profit Growth %
264.60%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2018
EPS (₹)
-4.41
Book Value (₹)
34.43
Dividend per Share (₹)
0.10
Cash EPS (₹)
-1.71
Operating Margin %
-8.41%
Net Margin %
-9.12%
ROE %
-12.01%
ROCE %
-10.52%
-8.48%
Debtor Days
93
Inventory Days
143
Payable Days
54
182
Debt to Equity (x)
0.09x
Interest Coverage (x)
-16.69x
3.31x
Revenue Growth %
-12.05%
Operating Profit Growth %
-270.74%
Net Profit Growth %
-197.35%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2019
EPS (₹)
2.75
Book Value (₹)
36.89
Dividend per Share (₹)
0.25
Cash EPS (₹)
1.26
Operating Margin %
6.45%
Net Margin %
4.33%
ROE %
7.72%
ROCE %
9.80%
5.43%
Debtor Days
50
Inventory Days
92
Payable Days
52
90
Debt to Equity (x)
0.04x
Interest Coverage (x)
13.08x
3.46x
Revenue Growth %
31.84%
Operating Profit Growth %
201.07%
Net Profit Growth %
162.47%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2020
EPS (₹)
3.00
Book Value (₹)
39.39
Dividend per Share (₹)
0.50
Cash EPS (₹)
1.37
Operating Margin %
3.49%
Net Margin %
2.48%
ROE %
7.88%
ROCE %
9.46%
5.53%
Debtor Days
24
Inventory Days
36
Payable Days
77
-17
Debt to Equity (x)
0.06x
Interest Coverage (x)
19.31x
2.79x
Revenue Growth %
-4.95%
Operating Profit Growth %
2.74%
Net Profit Growth %
9.07%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2021
EPS (₹)
6.51
Book Value (₹)
43.55
Dividend per Share (₹)
1.00
Cash EPS (₹)
2.77
Operating Margin %
6.25%
Net Margin %
4.54%
ROE %
15.70%
ROCE %
19.43%
10.90%
Debtor Days
17
Inventory Days
29
Payable Days
67
-22
Debt to Equity (x)
0.06x
Interest Coverage (x)
43.59x
2.98x
Revenue Growth %
18.53%
Operating Profit Growth %
112.25%
Net Profit Growth %
116.73%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2022
EPS (₹)
7.20
Book Value (₹)
50.68
Dividend per Share (₹)
4.00
Cash EPS (₹)
3.11
Operating Margin %
11.73%
Net Margin %
7.78%
ROE %
15.28%
ROCE %
21.23%
11.24%
Debtor Days
21
Inventory Days
45
Payable Days
75
-9
Debt to Equity (x)
0.00x
Interest Coverage (x)
94.48x
3.40x
Revenue Growth %
15.77%
Operating Profit Growth %
21.22%
Net Profit Growth %
10.53%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2023
EPS (₹)
10.20
Book Value (₹)
57.30
Dividend per Share (₹)
5.00
Cash EPS (₹)
4.26
Operating Margin %
15.51%
Net Margin %
10.39%
ROE %
18.89%
ROCE %
24.15%
14.29%
Debtor Days
26
Inventory Days
36
Payable Days
69
-8
Debt to Equity (x)
0.00x
Interest Coverage (x)
85.28x
4.89x
Revenue Growth %
8.79%
Operating Profit Growth %
40.18%
Net Profit Growth %
41.72%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2024
EPS (₹)
8.50
Book Value (₹)
64.43
Dividend per Share (₹)
5.00
Cash EPS (₹)
3.65
Operating Margin %
10.28%
Net Margin %
10.01%
ROE %
14.02%
ROCE %
17.72%
10.52%
Debtor Days
26
Inventory Days
29
Payable Days
55
0
Debt to Equity (x)
0.00x
Interest Coverage (x)
37.69x
9.39x
Revenue Growth %
-11.83%
Operating Profit Growth %
-18.90%
Net Profit Growth %
-15.94%
-16.70%
P/E (x)
13.17x
P/B (x)
4.34x
Dividend Yield %
1.79%
18.30x
Mar 2025
EPS (₹)
8.34
Book Value (₹)
32.83
Dividend per Share (₹)
2.50
Cash EPS (₹)
9.56
Operating Margin %
18.12%
Net Margin %
19.65%
ROE %
28.51%
ROCE %
33.14%
21.44%
Debtor Days
16
Inventory Days
20
Payable Days
33
2
Debt to Equity (x)
0.00x
Interest Coverage (x)
73.92x
6.22x
Revenue Growth %
28.76%
Operating Profit Growth %
83.21%
Net Profit Growth %
146.45%
-1.87%
P/E (x)
25.90x
P/B (x)
6.58x
Dividend Yield %
1.16%
22.02x

Shareholding Pattern

Numbers in percentages

TRADES
Jun 2024
68.04
1.10
0.85
Government
0.00
30.01
Sep 2024
67.97
2.30
0.11
Government
0.00
29.62
Dec 2024
67.81
2.10
0.00
Government
0.00
30.08
Mar 2025
67.78
2.10
0.00
Government
0.00
30.11
Jun 2025
67.65
2.17
0.05
Government
0.00
30.12
Sep 2025
67.54
2.12
0.08
Government
0.00
30.25
Dec 2025
67.39
2.12
0.15
Government
0.00
30.34
Mar 2026
67.89
2.44
0.22
Government
0.00
29.45
Jun 2026
69.05
2.30
0.62
Government
0.00
28.03

Documents

Announcements

Annual Reports

Credit Ratings

Nothing filed yet.

Concalls